Alidac Pharmaceuticals Ltd. - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Alidac Pharma.

Based on:

M-Cap below 100cr DeciZen not available

Alidac Pharmaceuticals Ltd. - (Amalgamated) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Alidac Pharma.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % -4.6%-2.1%-9.2%-6%-9.1%-7.7%31%15.1%15.4%-19.4%-
Value Creation
Index
-1.3-1.2-1.7-1.4NANA1.20.10.1-2.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.615.512.118.726.310111414155.856
Sales YoY Gr.-82.5%431.7%117.9%55.3%40.6%283.7%13%23.4%-60.3%-
Adj EPS -1.1-0.7-3.5-2.6-2.4-28.24.76.4-6.20
YoY Gr.-NANANANANANA-43.1%37.9%-196.7%-
BVPS (₹) 8.88.24.72.2-0.5-2.45.710.517.511.40
Adj Net
Profit
-2.4-1.5-7.9-5.7-5.4-4.418.210.414.3-13.80
Cash Flow from Ops. -1.5-0.1-4.5-0.6-1.91.50.922.414.9-13.7-
Debt/CF from Ops. -23.8-507.3-5.2-18.1-0.200000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 66.4%24.4%-17.9%-60.3%
Adj EPS NANA-191.2%-196.7%
BVPS3%NA26.3%-34.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
-11.6-6.4-24.2-13.2-10.3-826.111.413.7-13.10
Op. Profit
Mgn %
-295.5-70.3-61.6-5.5-8.7-225.415.413.5-26.9NAN
Net Profit
Mgn %
-415.9-147.6-142.7-47.3-28.9-16.718.19.110.2-24.80
Debt to
Equity
1.81.30.60.2000000-
Working Cap
Days
8054871191511552211441982015320
Cash Conv.
Cycle
18618770535856751611153230

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Alidac Pharmaceuticals Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 55.8 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 3 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 40.3

Management X-Ray of Alidac Pharma.:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Alidac Pharma. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Alidac Pharma.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales0.571.045.5312.0518.7126.31100.94114.08140.7455.83
Operating Expenses 2.251.768.9612.7321.2326.8575.5596.57121.9372.01
Manufacturing Costs0.430.242.404.514.845.995.388.5112.6611.90
Material Costs0.090.201.761.415.7410.5055.7671.8288.6036.59
Employee Cost 0.450.472.304.195.747.179.6512.7715.7215.81
Other Costs 1.280.852.502.614.913.184.763.464.947.71
Operating Profit -1.68-0.73-3.43-0.67-2.52-0.5425.3917.5118.80-16.18
Operating Profit Margin (%) -295.0%-70.3%-62.0%-5.6%-13.5%-2.1%25.2%15.3%13.4%-29.0%
Other Income 0.160.450.140.180.240.940.070.8121.32
Interest 002.151.940.570.080.010.010.020.01
Depreciation 0.840.942.403.163.044.653.784.544.705.53
Exceptional Items 0000000000
Profit Before Tax -2.37-1.22-7.84-5.61-5.89-4.3421.6613.7716.08-20.39
Tax -00-00003.582.890.57-6.64
Profit After Tax -2.37-1.22-7.83-5.61-5.89-4.3418.0810.8815.52-13.75
PAT Margin (%) -415.0%-117.0%-141.0%-46.5%-31.5%-16.5%17.9%9.5%11.0%-24.6%
Adjusted EPS (₹)-1.1-0.5-3.5-2.5-2.6-1.98.14.97.0-6.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 19.5427.2237.9948.385652.5985.6796.55112.1398.52
Share Capital 22.3331.2349.8365.8379.3380.3395.3395.3395.3395.33
Reserves -2.79-4.01-11.84-17.45-23.33-27.74-9.661.2216.803.19
Minority Interest0000000000
Debt3523.3311.6700.3900000
Long Term Debt3523.3311.670000000
Short Term Debt00000.3900000
Trade Payables0.7000.333.762.3316.776.183.8537.3225.54
Others Liabilities 1.1613.3912.53133.907.8527.9550.1132.1641.05
Total Liabilities 56.4063.9462.5165.1562.6277.21119.80150.50181.60165.11

Fixed Assets

Gross Block13.5613.3466.9367.1466.8768.6681.4082.8490.2995.11
Accumulated Depreciation4.095.017.3510.4813.1418.9322.6326.0530.3934.81
Net Fixed Assets 9.478.3459.5756.6653.7349.7358.7756.7959.9060.30
CWIP 27.4253.760000.870.394.584.3621.19
Investments 0000004.1019.0526.564.70
Inventories0.670.790.883.735.2819.4135.5953.1063.0148.82
Trade Receivables000.671.860.770.8716.816.6613.4919.60
Cash Equivalents 0.520.380.790.550.722.670.742.193.543.41
Others Assets 18.320.670.592.342.123.653.408.1310.747.10
Total Assets 56.4063.9462.5165.1562.6277.21119.80150.50181.60165.11

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity -1.47-0.07-4.52-0.64-1.871.510.9322.4014.90-13.70
PBT -2.37-1.22-7.84-5.61-5.89-4.3421.6613.7716.08-20.39
Adjustment 0.940.494.535.103.544.083.774.413.355.18
Changes in Working Capital -0.020.65-1.23-0.140.491.84-23.868.43-1.411.89
Tax Paid -0.030.010.020-0.01-0.09-0.63-4.21-3.13-0.38
Cash Flow From Investing Activity -5.76-4.420.140.021.04-1.53-12.27-6-6.02-8.29
Capex -0.86-4.420.11-0.011.01-1.60-12.37-6.75-8.02-9.61
Net Investments 00000000.721.951.31
Others -4.9000.030.040.030.070.100.040.050.01
Cash Flow From Financing Activity 7.504.404.780.330.992.0213.500-0.02-0
Net Proceeds from Shares 2.30818.60013.502.5013.50000
Net Proceeds from Borrowing 0000000000
Interest Paid -3.55-3.60-2.151.980.61-0.0800-0.02-0
Dividend Paid 0000000000
Others 8.750-11.67-1.65-13.13-0.390000
Net Cash Flow 0.27-0.080.40-0.290.1722.1616.408.86-21.99

Finance Ratio

PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)-12.27-6.42-54.38-72.93-303.560498.5160.149.51-42.56
ROCE (%)-4.63-2.07-9.21-6.03-9.13-7.731.0215.1315.43-19.36
Asset Turnover Ratio0.010.020.090.190.30.381.030.840.850.32
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/A0.052.060.96N/A
Working Capital Days
Receivable Days0044382511323826108
Inventory Days43625755698717099142151366
Payable Days5,26462434529194332752585314

Alidac Pharmaceuticals Ltd. - (Amalgamated) Stock News

Alidac Pharmaceuticals Ltd. - (Amalgamated) FAQs

The current trading price of Alidac Pharma. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Alidac Pharma. stood at ₹0.00.
The latest P/E ratio of Alidac Pharma. as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Alidac Pharma. as of 31-Dec-1969 is 0.00.
The 52-week high of Alidac Pharma. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alidac Pharma. is ₹55.83 ( Cr.) .

About Alidac Pharmaceuticals Ltd. - (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×